Medical Patent Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Response Biomedical
Response Biomedical officials provide details on the latest developments
May 6th, 2007
Response Biomedical officials provide details on the latest developments. This trend article is an immediate alert from NewsRx to identify the most recent news developments at Response Biomedical. Report 1: Response Biomedical Corporation (RBM) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the patent titled "Sensitive Immunochromatographic Assay." This patent covers key aspects of Response Biomedical's lateral flow immunoassays with the RAMP point-of-care testing platform. The RAMP platform provides highly sensitive and reliable results, typically in less than 15...
Source: Medical Patent Week (2007-05-06)
|
